Antiretroviral therapy | Page 4 of 4

International AIDS Society updates treatment guidelines for HIV infection

The availability of new antiretroviral drugs and formulations, including drugs in new classes, and recent data on treatment choices for antiretroviral-naive and -experienced patients warrant an update of the International AIDS Society?USA guidelines for the use of antiretroviral therapy in adult human immunodeficiency virus (HIV) infection. – An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

Monitoring AIDS treatment by physical signs is effective

When clinicians use simple physical signs of deteriorating health — such as weight loss or fever — these doctors can provide therapies almost as effective as those relying on the most advanced laboratory analysis. – When millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments. But according to a study being published in The Lancet, these concerns are as yet unfounded.

HIV persists in gut despite long term HIV therapy

Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. – HIV virus is not usually eradicated from infected individuals even after long term HIV therapy because of the persistence of HIV in hideouts known as viral reservoirs. One important reservoir is the gut, where HIV causes much of its damage due to the large number of HIV target cells that reside there.

Intelence, etravirine HIV Drug approved in US

The U.S. Food and Drug Administration approved etravirine tablets for the treatment of HIV infection in adults who have failed treatment with other antiretrovirals. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that helps to block an enzyme which HIV needs to multiply. – US FDA approved Tibotec Therapeutics’ Intelence, etravirine tablets for the treatment of HIV infection, to be used in combination with other anti-HIV medications, in adults who have failed treatment with other antiretrovirals.

HIV AIDS drug cost trends in Brazil

Brazil facing significant challenges with the rising cost of providing universal access to HIV/AIDS treatment. – AIDS continues to be a staggering global public health problem. The World Health Organization estimates that two million people in developing countries (or 25% of those in need in developing countries) receive treatment known as HAART (highly active antiretroviral therapy), more commonly known as “AIDS cocktails.”